These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 10862157

  • 1. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
    Talmaciu I, Varlotta L, Mortensen J, Schidlow DV.
    Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
    [Abstract] [Full Text] [Related]

  • 2. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.
    Marchac V, Equi A, Le Bihan-Benjamin C, Hodson M, Bush A.
    Eur Respir J; 2004 Jan; 23(1):98-102. PubMed ID: 14738239
    [Abstract] [Full Text] [Related]

  • 3. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.
    Graff GR, Burns JL.
    Chest; 2002 Jun; 121(6):1754-60. PubMed ID: 12065335
    [Abstract] [Full Text] [Related]

  • 4. Stenotrophomonas maltophilia: A marker of lung disease severity.
    Berdah L, Taytard J, Leyronnas S, Clement A, Boelle PY, Corvol H.
    Pediatr Pulmonol; 2018 Apr; 53(4):426-430. PubMed ID: 29314745
    [Abstract] [Full Text] [Related]

  • 5. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
    Frost F, Nazareth D, Shaw M, Walshaw MJ.
    J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
    [Abstract] [Full Text] [Related]

  • 6. Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment.
    Willsey GG, Eckstrom K, LaBauve AE, Hinkel LA, Schutz K, Meagher RJ, LiPuma JJ, Wargo MJ.
    J Bacteriol; 2019 Aug 01; 201(15):. PubMed ID: 31109991
    [Abstract] [Full Text] [Related]

  • 7. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
    Anderson SW, Stapp JR, Burns JL, Qin X.
    J Clin Microbiol; 2007 Feb 01; 45(2):529-35. PubMed ID: 17135443
    [Abstract] [Full Text] [Related]

  • 8. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
    Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, Tom S, Tullis E, Ratjen F.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):635-40. PubMed ID: 20889901
    [Abstract] [Full Text] [Related]

  • 9. Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.
    Vidigal PG, Dittmer S, Steinmann E, Buer J, Rath PM, Steinmann J.
    Int J Med Microbiol; 2014 Jul 01; 304(5-6):613-9. PubMed ID: 24836944
    [Abstract] [Full Text] [Related]

  • 10. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
    Capaldo C, Beauruelle C, Saliou P, Rault G, Ramel S, Héry-Arnaud G.
    Respir Med Res; 2020 Nov 01; 78():100757. PubMed ID: 32759054
    [Abstract] [Full Text] [Related]

  • 11. Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH.
    Gallagher T, Phan J, Oliver A, Chase AB, England WE, Wandro S, Hendrickson C, Riedel SF, Whiteson K.
    J Bacteriol; 2019 Apr 01; 201(7):. PubMed ID: 30642989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection.
    Pathmanathan A, Waterer GW.
    Eur Respir J; 2005 May 01; 25(5):911-4. PubMed ID: 15863651
    [Abstract] [Full Text] [Related]

  • 14. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M, Kragh KN, Bjarnsholt T, Line L, Hansen CR, Dalbøge CS, Hansen N, Kühl M, Høiby N, Jensen PØ.
    Int J Med Microbiol; 2015 Jan 01; 305(1):1-10. PubMed ID: 25441256
    [Abstract] [Full Text] [Related]

  • 15. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
    Goss CH, Otto K, Aitken ML, Rubenfeld GD.
    Am J Respir Crit Care Med; 2002 Aug 01; 166(3):356-61. PubMed ID: 12153970
    [Abstract] [Full Text] [Related]

  • 16. Stenotrophomonas maltophilia phenotypic and genotypic features through 4-year cystic fibrosis lung colonization.
    Alcaraz E, Centrón D, Camicia G, Quiroga MP, Di Conza J, Passerini de Rossi B.
    J Med Microbiol; 2021 Jan 01; 70(1):. PubMed ID: 33258754
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
    Wu K, Yau YC, Matukas L, Waters V.
    Antimicrob Agents Chemother; 2013 Mar 01; 57(3):1546-8. PubMed ID: 23295930
    [Abstract] [Full Text] [Related]

  • 19. Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.
    Marzuillo C, De Giusti M, Tufi D, Giordano A, Del Cimmuto A, Quattrucci S, Mancini C, Villari P.
    Infect Control Hosp Epidemiol; 2009 Aug 01; 30(8):753-8. PubMed ID: 19583515
    [Abstract] [Full Text] [Related]

  • 20. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW, Nguyen CD, Foster JM, Burns JL.
    J Clin Microbiol; 2001 Oct 01; 39(10):3597-602. PubMed ID: 11574579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.